Your Trusted Source for Biopharma News

Editorial

View All
Your Trusted Source for Biopharma News
Editorial Biopharma's 2026 Playbook: AI, M&A, and the Race for Pipeline Security

The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…

MindWalk and Teva Team Up to Advance AI Antibody Discovery
EditorialMindWalk and Teva Team Up to Advance AI Antibody Discovery

Over the past few years, applying AI to drug discovery has become a crowded, well-funded field. In

Regenerative Medicine and Rare Disease Therapy Innovations
EditorialRegenerative Medicine and Rare Disease Therapy Innovations

The move from research-level discovery to established clinical use is a critical juncture that

Seven Biopharma Trends to Watch in 2026
EditorialSeven Biopharma Trends to Watch in 2026

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

From Breakthroughs to Scale: Biopharma Platforms Shaping 2026
EditorialFrom Breakthroughs to Scale: Biopharma Platforms Shaping 2026

In 2026, boards and customers are asking a direct question: can promising science be turned into

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Can We Automate Resolution Selection in Single-Cell Clustering?
Tech & Innovation Can We Automate Resolution Selection in Single-Cell Clustering?

The tendency of clustering algorithms to fluctuate between different partitions creates a reproducibility crisis that necessitates a standardized, unsupervised solution. In the complex world of single-cell transcriptomics, the ability to accurately categorize individual cells into distinct

Super-Resolution MRI Predicts Cervical Cancer Vascular Invasion
Tech & InnovationSuper-Resolution MRI Predicts Cervical Cancer Vascular Invasion

While T2-weighted sequences provide structural detail, the diffusion of water molecules within the

New Clinical Process Developed for FAP-Targeting PET Tracers
Tech & InnovationNew Clinical Process Developed for FAP-Targeting PET Tracers

To combat the risks of radiolysis during high-activity production runs, the final formulation of

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later